Wave Life Sciences (WVE) Assets Average (2015 - 2026)

Wave Life Sciences' Assets Average history runs 12 years deep, the most recent figure standing at $611.0 million for Q1 2026.

• Quarterly Assets Average rose 90.78% year-over-year to $611.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $611.0 million (up 90.78% YoY) and the FY2025 annual result came in at $495.4 million, up 57.97% from the prior year.
• Assets Average was $611.0 million for Q1 2026 at Wave Life Sciences, up from $439.9 million in the prior quarter.
• Across five years, Assets Average topped out at $611.0 million in Q1 2026 and bottomed at $163.9 million in Q4 2022.
• A 5-year average of $273.6 million and a median of $246.9 million in 2025 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2022 — Assets Average slipped 28.27% — and 2026, when it jumped 90.78%.
• Wave Life Sciences' Assets Average stood at $163.9 million in 2022, then jumped by 44.82% to $237.4 million in 2023, then soared by 49.67% to $355.4 million in 2024, then gained by 23.8% to $439.9 million in 2025, then surged by 38.89% to $611.0 million in 2026.
• Business Quant data shows WVE's Assets Average at $611.0 million in Q1 2026, $439.9 million in Q4 2025, and $246.9 million in Q3 2025.